(Note: For PDF File Swipe To The End Of Article)

Pulmonary Embolism

Introduction

Pulmonary embolism (PE) is a serious and potentially life-threatening cardiovascular and respiratory emergency that occurs when a thrombus or other embolic material obstructs one or more branches of the pulmonary arterial circulation. In most cases, the embolus originates from deep veins of the lower extremities or pelvis and travels through the venous system to the lungs. This process interrupts pulmonary blood flow, impairs gas exchange, increases pulmonary vascular resistance, and may eventually lead to right ventricular failure and sudden death if not recognized and treated promptly.

Pulmonary embolism is considered a major component of venous thromboembolism (VTE), along with deep vein thrombosis (DVT). The condition may range from small asymptomatic emboli discovered incidentally on imaging to massive emboli causing hemodynamic collapse and cardiac arrest. Because its clinical presentation is highly variable and often nonspecific, PE is frequently underdiagnosed or diagnosed late. Early suspicion and timely intervention significantly improve outcomes and reduce mortality.

The disease represents a major global health burden and is one of the leading preventable causes of in-hospital death. Many patients who develop PE have identifiable risk factors such as prolonged immobilization, recent surgery, malignancy, trauma, pregnancy, obesity, or inherited hypercoagulable states. However, pulmonary embolism can also occur in otherwise healthy individuals without obvious precipitating factors.

The severity of pulmonary embolism depends on several factors including the size and number of emboli, the extent of pulmonary artery obstruction, preexisting cardiopulmonary disease, and the patient’s overall physiological reserve. Large emboli may obstruct the main pulmonary arteries and rapidly cause severe hypoxemia, hypotension, and shock, whereas smaller emboli may produce mild symptoms or remain clinically silent.

Pulmonary embolism should always be considered in patients presenting with sudden onset dyspnea, pleuritic chest pain, unexplained tachycardia, hypoxemia, syncope, or hemoptysis. Due to its potentially fatal nature, clinicians must maintain a high index of suspicion, especially in high-risk individuals.

Epidemiology

Pulmonary embolism is a common cardiovascular disorder worldwide and remains a significant cause of morbidity and mortality. Venous thromboembolism, which includes DVT and PE, affects millions of individuals annually. The incidence increases markedly with age, although PE can occur at any stage of life, including childhood and pregnancy.

The annual incidence of pulmonary embolism is estimated to range from 60 to 100 cases per 100,000 population. However, the true incidence is likely higher because many cases remain undiagnosed, especially when symptoms are mild or nonspecific. Autopsy studies have shown that a considerable number of fatal pulmonary emboli are not recognized before death.

Pulmonary embolism is more common in hospitalized patients than in the general population. Prolonged bed rest, major surgery, critical illness, cancer, and trauma contribute significantly to hospital-associated venous thromboembolism. Postoperative patients, especially those undergoing orthopedic surgery such as hip or knee replacement, are particularly vulnerable.

Age is one of the strongest risk factors. The incidence rises sharply after the age of 60 years due to increased immobility, comorbid illnesses, and age-related changes in coagulation pathways. Elderly patients also tend to have worse outcomes and higher mortality rates.

Gender differences have also been observed. Before middle age, women may have slightly higher risk due to pregnancy, oral contraceptive use, and hormone replacement therapy. In older populations, men tend to have a somewhat higher incidence and recurrence rate.

Cancer-associated thrombosis is another major contributor to pulmonary embolism. Patients with malignancies such as pancreatic cancer, lung cancer, ovarian cancer, gastric cancer, and brain tumors are at particularly high risk due to hypercoagulability induced by tumor cells and cancer treatments.

The mortality associated with untreated massive pulmonary embolism is extremely high. With appropriate diagnosis and anticoagulant therapy, mortality decreases significantly. Early identification of high-risk patients and implementation of preventive measures in hospitals have helped reduce the incidence of fatal PE in many healthcare settings.

Anatomy of Pulmonary Circulation

Understanding pulmonary embolism requires knowledge of pulmonary vascular anatomy and circulation. The pulmonary circulation begins at the right ventricle, which pumps deoxygenated blood into the pulmonary trunk. The pulmonary trunk divides into right and left pulmonary arteries that carry blood to the lungs.

Within the lungs, pulmonary arteries branch repeatedly into smaller arteries, arterioles, and eventually capillaries surrounding the alveoli. Gas exchange occurs across the alveolar-capillary membrane where carbon dioxide is removed and oxygen enters the bloodstream. Oxygenated blood then returns to the left atrium through pulmonary veins.

The pulmonary vascular system is normally a low-pressure, low-resistance circulation. This allows the right ventricle to pump blood efficiently without generating excessive pressure. When emboli obstruct pulmonary arteries, pulmonary vascular resistance increases suddenly. As resistance rises, the right ventricle must work harder to maintain blood flow.

Acute obstruction of major pulmonary arteries can overwhelm the right ventricle because it is not adapted to pump against high resistance. Right ventricular dilation, dysfunction, and ischemia may develop rapidly. Reduced right ventricular output subsequently decreases left ventricular filling, leading to hypotension and shock.

The lungs also possess a dual blood supply through bronchial arteries arising from the systemic circulation. This collateral supply explains why pulmonary infarction does not occur in all patients with pulmonary embolism. However, when distal emboli obstruct smaller vessels and collateral circulation is insufficient, pulmonary infarction may occur, producing pleuritic pain and hemoptysis.

Etiology and Causes

Pulmonary embolism most commonly results from thromboemboli originating in the deep veins of the legs or pelvis. These thrombi detach, travel through the venous circulation, pass through the right side of the heart, and lodge in pulmonary arteries.

Deep vein thrombosis is therefore the principal underlying cause of pulmonary embolism. Venous thrombi typically form in areas of sluggish blood flow such as calf veins, femoral veins, or iliac veins. Once dislodged, the embolus may partially or completely obstruct pulmonary circulation.

Several other less common causes of pulmonary embolism exist besides thrombotic emboli.

Fat Embolism

Fat embolism may occur after long bone fractures, orthopedic trauma, or bone marrow injury. Fat droplets enter the bloodstream and embolize pulmonary vessels, causing respiratory distress and neurological symptoms.

Air Embolism

Air embolism occurs when air enters the venous circulation during surgery, trauma, central venous catheter manipulation, or diving accidents. Large volumes of air can obstruct pulmonary outflow and impair oxygenation.

Amniotic Fluid Embolism

This rare but catastrophic obstetric emergency occurs when amniotic fluid enters maternal circulation during labor or delivery. It causes severe respiratory failure, shock, and disseminated intravascular coagulation.

Septic Embolism

Infective material from endocarditis or infected venous catheters can embolize to the lungs, producing pulmonary infiltrates, abscesses, and sepsis.

Tumor Embolism

Malignant cells may invade veins and embolize to pulmonary circulation, particularly in advanced cancers.

Despite these alternative causes, thromboembolism remains by far the most common etiology of pulmonary embolism in clinical practice.

Virchow’s Triad

The pathogenesis of venous thrombosis is classically explained by Virchow’s triad, which includes three major factors promoting thrombus formation.

Venous Stasis

Slow or stagnant blood flow encourages clot formation by allowing accumulation of activated clotting factors and reducing clearance of thrombi. Venous stasis commonly occurs during prolonged immobilization, bed rest, long-distance travel, paralysis, or heart failure.

Endothelial Injury

Damage to vascular endothelium exposes subendothelial collagen and activates platelets and coagulation pathways. Trauma, surgery, fractures, intravenous catheters, and inflammation can all injure venous endothelium.

Hypercoagulability

Hypercoagulable states increase the tendency of blood to clot. These may be inherited or acquired. Examples include malignancy, pregnancy, oral contraceptive use, antiphospholipid syndrome, factor V Leiden mutation, and protein C or protein S deficiency.

Most patients with pulmonary embolism have one or more components of Virchow’s triad contributing to thrombus development.

Risk Factors

Numerous risk factors increase the likelihood of pulmonary embolism. These risk factors may be temporary, persistent, inherited, or acquired.

Immobilization

Prolonged immobilization is one of the most important risk factors. Bed rest, hospitalization, paralysis, sedentary lifestyle, and long-distance travel reduce venous blood flow and promote thrombosis.

Surgery

Major surgery, especially orthopedic, pelvic, abdominal, and cancer surgeries, substantially increases thrombotic risk due to endothelial injury and postoperative immobility.

Trauma

Fractures and severe trauma damage blood vessels and increase coagulation activity. Long bone fractures are particularly associated with thromboembolism.

Malignancy

Cancer promotes hypercoagulability through tumor-related procoagulant substances, inflammation, chemotherapy, and reduced mobility.

Pregnancy and Postpartum State

Pregnancy is a hypercoagulable state caused by hormonal changes and venous compression by the enlarging uterus. Risk remains elevated during the postpartum period.

Oral Contraceptives and Hormonal Therapy

Estrogen-containing medications increase clotting factor synthesis and elevate the risk of venous thrombosis.

Previous Venous Thromboembolism

A history of prior DVT or PE significantly increases recurrence risk.

Obesity

Obesity contributes to venous stasis, chronic inflammation, and endothelial dysfunction.

Smoking

Smoking damages vascular endothelium and enhances thrombotic tendency.

Heart Failure and Chronic Disease

Heart failure, chronic lung disease, nephrotic syndrome, inflammatory bowel disease, and autoimmune disorders increase thrombosis risk.

Inherited Thrombophilia

Inherited disorders such as factor V Leiden mutation, prothrombin gene mutation, protein C deficiency, protein S deficiency, and antithrombin deficiency predispose individuals to recurrent venous thrombosis.

Classification of Pulmonary Embolism

Pulmonary embolism can be classified according to severity, hemodynamic impact, and anatomical extent.

Massive Pulmonary Embolism

Massive PE is characterized by sustained hypotension, shock, or cardiac arrest due to severe obstruction of pulmonary blood flow. This type carries high mortality and requires urgent aggressive management.

Submassive Pulmonary Embolism

Submassive PE involves right ventricular dysfunction or myocardial injury without systemic hypotension. Patients are hemodynamically stable but remain at risk of deterioration.

Low-Risk Pulmonary Embolism

Low-risk PE occurs in hemodynamically stable patients without evidence of right ventricular strain or myocardial injury.

Saddle Pulmonary Embolism

A saddle embolus lodges at the bifurcation of the main pulmonary artery and may obstruct blood flow to both lungs. Although potentially fatal, some patients remain surprisingly stable depending on clot burden and cardiopulmonary reserve.

Pathophysiology

The pathophysiology of pulmonary embolism involves mechanical obstruction of pulmonary arteries and complex cardiopulmonary responses.

When an embolus obstructs pulmonary vessels, pulmonary vascular resistance rises suddenly. This increases right ventricular afterload and causes right ventricular dilation. As right ventricular pressure rises, the interventricular septum may shift toward the left ventricle, impairing left ventricular filling and reducing cardiac output.

Ventilation-perfusion mismatch develops because affected lung regions are ventilated but not perfused. This increases physiological dead space and causes hypoxemia. Reflex bronchoconstriction and release of vasoactive mediators further worsen gas exchange abnormalities.

Large emboli may produce severe hemodynamic compromise. Reduced cardiac output leads to hypotension, tissue hypoperfusion, syncope, and shock. Myocardial ischemia may occur due to increased right ventricular oxygen demand and reduced coronary perfusion.

Small distal emboli may cause pulmonary infarction when collateral bronchial circulation is insufficient. Pulmonary infarction results in pleuritic chest pain, inflammation, and hemoptysis.

Neurohumoral activation also contributes to disease manifestations. Platelet activation and release of serotonin, thromboxane, and inflammatory mediators cause vasoconstriction and further elevate pulmonary arterial pressure.

Clinical Manifestations

The clinical presentation of pulmonary embolism is highly variable and depends on the size, location, and number of emboli as well as the patient’s cardiopulmonary reserve. Some patients remain asymptomatic, while others develop sudden cardiovascular collapse and death. Because symptoms are often nonspecific, pulmonary embolism is commonly referred to as a “great masquerader” in medicine.

Symptoms may appear abruptly or evolve gradually over several hours. In many cases, manifestations are subtle and easily mistaken for pneumonia, myocardial infarction, anxiety disorders, asthma exacerbation, or musculoskeletal chest pain.

Dyspnea

Sudden onset dyspnea is the most common symptom of pulmonary embolism. Patients often describe difficulty breathing, air hunger, or inability to take a deep breath. Dyspnea may occur at rest or during exertion and can vary from mild shortness of breath to severe respiratory distress.

In massive pulmonary embolism, dyspnea develops abruptly and may rapidly progress to cyanosis and respiratory failure. In smaller emboli, breathlessness may be the only complaint.

Pleuritic Chest Pain

Pleuritic chest pain is another common symptom. The pain is typically sharp, stabbing, and worsens during deep inspiration, coughing, or movement. This occurs when emboli involve peripheral pulmonary arteries near the pleural surface, leading to pleural inflammation or pulmonary infarction.

Pain may be localized to one side of the chest and is sometimes confused with pleurisy, rib injury, or pneumonia.

Cough

Many patients develop cough, which may initially be dry but can later become productive. Cough is usually mild but may persist for several days.

Hemoptysis

Hemoptysis occurs when pulmonary infarction causes alveolar hemorrhage. It is usually mild and manifests as blood-streaked sputum rather than massive bleeding. Hemoptysis strongly suggests peripheral pulmonary infarction but is not present in all cases.

Tachypnea

Rapid breathing is one of the most frequent physical findings. Patients may appear anxious and distressed due to hypoxemia and impaired gas exchange.

Tachycardia

Sinus tachycardia is common and may be the earliest sign of pulmonary embolism. Heart rate elevation reflects sympathetic activation, hypoxemia, and cardiovascular stress.

Syncope

Syncope or near-syncope may occur in massive pulmonary embolism due to sudden reduction in cardiac output and cerebral perfusion. Syncope is considered a concerning feature associated with severe disease and increased mortality.

Cyanosis

Severe hypoxemia may produce bluish discoloration of lips, fingers, and mucous membranes. Cyanosis is more commonly observed in massive pulmonary embolism.

Anxiety and Restlessness

Many patients experience unexplained anxiety, agitation, or a feeling of impending doom. These symptoms may result from hypoxemia and sympathetic nervous system activation.

Fever

Low-grade fever may occur due to pulmonary inflammation and infarction. Fever can occasionally lead clinicians to incorrectly diagnose pneumonia instead of pulmonary embolism.

Sudden Death

In catastrophic cases, especially with massive emboli obstructing major pulmonary arteries, sudden death may occur before diagnosis is established. Cardiac arrest caused by pulseless electrical activity is a classic presentation of fatal massive pulmonary embolism.

Signs on Physical Examination

Physical findings in pulmonary embolism are often nonspecific and may even be absent. However, careful examination can provide important clues.

General Appearance

Patients may appear anxious, restless, tachypneic, and distressed. Severe cases may present with altered mental status or collapse.

Vital Signs

Common abnormalities include:

Tachycardia
Tachypnea
Mild fever
Hypoxemia
Hypotension in massive PE

Persistent hypotension suggests hemodynamic instability and severe obstruction of pulmonary circulation.

Respiratory Examination

Findings may include:

Rapid shallow breathing
Reduced breath sounds
Pleural rub
Crackles over areas of pulmonary infarction

However, chest examination may be surprisingly normal despite significant embolic disease.

Cardiovascular Examination

Massive pulmonary embolism may produce:

Elevated jugular venous pressure
Right ventricular heave
Loud pulmonary component of second heart sound (P2)
Tricuspid regurgitation murmur

These findings reflect acute pulmonary hypertension and right ventricular strain.

Signs of Deep Vein Thrombosis

Since most pulmonary emboli arise from lower limb DVT, examination should assess for:

Unilateral leg swelling
Calf tenderness
Warmth
Erythema
Dilated superficial veins

Presence of DVT signs strongly supports the diagnosis of pulmonary embolism.

Deep Vein Thrombosis and Its Relationship to Pulmonary Embolism

Deep vein thrombosis and pulmonary embolism are closely related manifestations of venous thromboembolism. In most patients, pulmonary emboli originate from thrombi formed in deep veins of the lower extremities.

Thrombi usually develop in calf veins and may extend proximally into popliteal, femoral, or iliac veins. Portions of the thrombus can detach and travel through the inferior vena cava into the right side of the heart before reaching pulmonary arteries.

Not all patients with DVT develop pulmonary embolism, and not all patients with PE have clinically apparent DVT. In many cases, deep vein thrombosis remains silent.

Symptoms of DVT

Common symptoms include:

Unilateral leg pain
Swelling
Tenderness
Warmth
Redness

Calf pain worsened by dorsiflexion of the foot is known as Homan sign, although it lacks sensitivity and specificity.

Importance of Recognizing DVT

Early recognition and treatment of DVT are critical because anticoagulation can prevent clot propagation and pulmonary embolization. Hospitalized and postoperative patients should routinely undergo risk assessment for venous thromboembolism prophylaxis.

Hemodynamic Effects of Pulmonary Embolism

Pulmonary embolism causes profound hemodynamic changes, particularly when embolic burden is large.

Increased Pulmonary Vascular Resistance

Mechanical obstruction reduces the cross-sectional area of pulmonary vasculature. This increases resistance to blood flow and elevates pulmonary artery pressure.

Right Ventricular Overload

The right ventricle normally pumps against low resistance. Acute elevation in pulmonary pressure causes right ventricular dilation and dysfunction because the thin-walled right ventricle cannot adapt rapidly.

Reduced Left Ventricular Filling

As the right ventricle enlarges, the interventricular septum shifts toward the left ventricle. This impairs left ventricular filling and reduces systemic cardiac output.

Hypotension and Shock

Reduced cardiac output combined with impaired oxygenation leads to systemic hypotension and shock. Severe hypotension is associated with high mortality and indicates massive pulmonary embolism.

Myocardial Ischemia

Right ventricular strain increases oxygen demand while coronary perfusion falls due to hypotension. This may result in myocardial ischemia and elevated cardiac biomarkers.

Pulmonary Infarction

Pulmonary infarction occurs when embolic obstruction causes ischemic necrosis of lung tissue. Although the lungs possess dual circulation, infarction may occur when bronchial arterial supply is insufficient.

Features of Pulmonary Infarction

Patients typically develop:

Sharp pleuritic chest pain
Hemoptysis
Fever
Localized pleural rub

Peripheral wedge-shaped infiltrates may appear on imaging studies.

Histopathology

Pulmonary infarcts are usually hemorrhagic because blood leaks from bronchial circulation into necrotic tissue. Infarction commonly affects lower lobes due to higher blood flow in dependent lung regions.

Diagnostic Approach

Diagnosing pulmonary embolism requires integration of clinical suspicion, risk assessment tools, laboratory testing, and imaging studies. Because symptoms overlap with many cardiopulmonary conditions, no single clinical feature confirms or excludes PE.

The diagnostic approach begins with estimation of pretest probability using validated scoring systems such as the Wells score or Geneva score. Patients are then stratified into low, intermediate, or high probability categories.

Initial Assessment

The first step is rapid evaluation of:

Airway
Breathing
Circulation
Hemodynamic stability

Unstable patients require urgent intervention while diagnostic testing proceeds simultaneously.

Clinical Suspicion

Pulmonary embolism should be suspected in patients with:

Sudden unexplained dyspnea
Pleuritic chest pain
Tachycardia
Hypoxemia
Syncope
Signs of DVT
Recent surgery or immobilization

Clinical suspicion remains the cornerstone of diagnosis because many investigations are nonspecific.

Wells Score for Pulmonary Embolism

The Wells score is a widely used clinical prediction rule that estimates the probability of pulmonary embolism.

Factors included in the score are:

Clinical signs of DVT
PE more likely than alternative diagnosis
Heart rate greater than 100/min
Recent surgery or immobilization
Previous DVT or PE
Hemoptysis
Malignancy

Patients are categorized into:

Low probability
Intermediate probability
High probability

Alternatively, a simplified two-tier model classifies patients as:

PE unlikely
PE likely

The Wells score helps guide further testing and reduces unnecessary imaging.

Geneva Score

The Geneva score is another validated clinical prediction tool based entirely on objective criteria.

It includes:

Age
Heart rate
Previous DVT or PE
Surgery or fracture
Hemoptysis
Active cancer
Unilateral leg pain

Like the Wells score, it stratifies patients according to probability of pulmonary embolism.

D-Dimer Testing

D-dimer is a fibrin degradation product released when cross-linked fibrin is broken down. Elevated levels indicate recent or ongoing coagulation and fibrinolysis.

Role in Pulmonary Embolism

D-dimer testing is highly sensitive but poorly specific. A normal D-dimer level in low-risk patients effectively excludes pulmonary embolism.

However, elevated D-dimer levels occur in many other conditions including:

Infection
Cancer
Pregnancy
Trauma
Surgery
Advanced age
Inflammation

Therefore, a positive D-dimer does not confirm PE and requires further imaging.

Age-Adjusted D-Dimer

In elderly patients, age-adjusted D-dimer thresholds improve specificity and reduce unnecessary imaging studies.

Arterial Blood Gas Analysis

Arterial blood gas findings in pulmonary embolism may include:

Hypoxemia
Respiratory alkalosis
Low PaCO₂ due to hyperventilation

However, ABG results can be normal, especially in smaller emboli. Thus, normal blood gases do not exclude pulmonary embolism.

Electrocardiography (ECG)

Electrocardiography is routinely performed in patients suspected of pulmonary embolism because it helps evaluate cardiac status and exclude other causes of chest pain such as myocardial infarction or arrhythmias. Although ECG findings in pulmonary embolism are neither sensitive nor specific, certain patterns strongly suggest right heart strain caused by acute pulmonary hypertension.

Sinus Tachycardia

Sinus tachycardia is the most common ECG abnormality in pulmonary embolism. It reflects sympathetic stimulation, hypoxemia, anxiety, and cardiovascular stress. In some patients, tachycardia may be the only abnormal finding.

S1Q3T3 Pattern

The classic S1Q3T3 pattern consists of:

Deep S wave in lead I
Q wave in lead III
Inverted T wave in lead III

This pattern indicates acute right ventricular strain but is present in only a minority of cases. Despite its low sensitivity, it remains a well-known ECG sign associated with pulmonary embolism.

Right Bundle Branch Block

Acute right ventricular overload may produce incomplete or complete right bundle branch block.

T-Wave Inversions

T-wave inversions in right precordial leads (V1–V4) and inferior leads may occur due to right ventricular ischemia and strain.

Right Axis Deviation

Massive pulmonary embolism may shift the cardiac axis toward the right due to right ventricular pressure overload.

Atrial Arrhythmias

Atrial fibrillation and other supraventricular arrhythmias occasionally develop, particularly in elderly patients or those with underlying heart disease.

Although ECG abnormalities can support the diagnosis, a normal ECG does not exclude pulmonary embolism.

Chest X-Ray Findings

Chest radiography is usually performed early in the evaluation of dyspnea or chest pain. Many patients with pulmonary embolism have normal chest X-rays despite significant disease. However, radiographic findings may help exclude pneumonia, pneumothorax, pulmonary edema, or other pulmonary disorders.

Common Findings

Possible chest X-ray abnormalities include:

Small pleural effusions
Elevated hemidiaphragm
Linear atelectasis
Peripheral wedge-shaped opacity
Enlarged pulmonary arteries

Hampton Hump

A Hampton hump is a wedge-shaped peripheral opacity representing pulmonary infarction. Although classically associated with PE, it is relatively uncommon.

Westermark Sign

Westermark sign refers to focal oligemia distal to an occluded pulmonary artery, producing an area of decreased vascular markings.

Palla Sign

Enlargement of the right descending pulmonary artery is called Palla sign.

Chest X-ray findings are usually nonspecific and primarily serve to exclude alternative diagnoses.

CT Pulmonary Angiography (CTPA)

CT pulmonary angiography is the gold standard imaging modality for diagnosing pulmonary embolism in most clinical settings. It provides rapid, highly sensitive visualization of pulmonary arteries and can directly identify intraluminal thrombi.

Technique

Contrast material is injected intravenously while CT imaging captures pulmonary arterial circulation. Emboli appear as filling defects within contrast-opacified vessels.

Advantages

CTPA offers several advantages:

High sensitivity and specificity
Rapid availability
Visualization of alternative thoracic diagnoses
Assessment of clot burden
Evaluation of right ventricular enlargement

Findings in Pulmonary Embolism

Typical findings include:

Intraluminal filling defects
Complete arterial occlusion
Saddle embolus at pulmonary artery bifurcation
Peripheral infarcts
Right ventricular enlargement

Limitations

CTPA may be unsuitable in patients with:

Severe renal failure
Contrast allergy
Pregnancy requiring radiation minimization
Hemodynamic instability preventing transport

Despite these limitations, CTPA remains the primary diagnostic imaging study for pulmonary embolism.

Ventilation-Perfusion (V/Q) Scan

Ventilation-perfusion scanning evaluates the relationship between airflow and blood flow within the lungs.

Principle

The ventilation component assesses air distribution, while the perfusion component assesses pulmonary blood flow. Pulmonary embolism produces areas with preserved ventilation but absent perfusion, known as ventilation-perfusion mismatch.

Indications

V/Q scanning is particularly useful in:

Pregnancy
Contrast allergy
Renal insufficiency
Patients unsuitable for CT angiography

Interpretation

Results are categorized as:

Normal
Low probability
Intermediate probability
High probability for PE

A normal V/Q scan effectively excludes pulmonary embolism.

Limitations

Intermediate probability scans may be nondiagnostic and require further testing.

Pulmonary Angiography

Conventional pulmonary angiography was historically considered the definitive diagnostic test for pulmonary embolism. However, due to its invasive nature and the widespread availability of CTPA, it is now rarely used.

Procedure

Contrast dye is injected directly into pulmonary arteries through a catheter inserted via central venous access.

Findings

Emboli appear as intraluminal filling defects or abrupt vessel cutoffs.

Risks

Potential complications include:

Arrhythmias
Bleeding
Contrast nephropathy
Vascular injury

Pulmonary angiography is generally reserved for complex cases or interventional procedures.

Echocardiography in Pulmonary Embolism

Echocardiography is especially useful in unstable patients with suspected massive pulmonary embolism.

Role of Echocardiography

It evaluates:

Right ventricular size and function
Pulmonary hypertension
Tricuspid regurgitation
Cardiac thrombi

Findings Suggestive of PE

Common findings include:

Right ventricular dilation
Hypokinesis of the right ventricle
Flattening of interventricular septum
Elevated pulmonary artery pressure

McConnell Sign

McConnell sign refers to right ventricular free wall hypokinesis with preserved apical contraction and may suggest acute PE.

Although echocardiography cannot definitively confirm pulmonary embolism, it is valuable for risk stratification and assessment of hemodynamic compromise.

Lower Limb Venous Ultrasound

Compression ultrasonography is frequently performed to detect deep vein thrombosis in patients suspected of pulmonary embolism.

Findings

Failure of veins to compress during ultrasound strongly suggests thrombosis.

Importance

Detection of proximal DVT in a patient with suspected PE may justify anticoagulant therapy even if pulmonary imaging is inconclusive.

Ultrasound is noninvasive, inexpensive, and widely available.

Cardiac Biomarkers

Cardiac biomarkers provide prognostic information in pulmonary embolism.

Troponins

Elevated troponin levels indicate right ventricular myocardial injury caused by acute pressure overload. Increased troponin is associated with higher mortality and severe disease.

Brain Natriuretic Peptide (BNP)

BNP and NT-proBNP rise in response to ventricular strain and correlate with right ventricular dysfunction.

These biomarkers assist in risk stratification but are not diagnostic.

Differential Diagnosis

Pulmonary embolism can mimic many cardiopulmonary conditions. Differential diagnosis includes:

Myocardial Infarction

Both conditions may present with chest pain, dyspnea, and elevated cardiac biomarkers.

Pneumonia

Fever, cough, pleuritic pain, and infiltrates may resemble pulmonary infarction.

Pneumothorax

Sudden dyspnea and pleuritic chest pain can occur in both conditions.

Heart Failure

Dyspnea and hypoxemia may mimic acute pulmonary edema.

Asthma and COPD Exacerbation

Wheezing and respiratory distress sometimes obscure underlying pulmonary embolism.

Pericarditis

Sharp pleuritic chest pain may resemble PE-related pain.

Aortic Dissection

Severe chest pain and hemodynamic instability require differentiation from massive PE.

Anxiety and Panic Attacks

Hyperventilation and chest discomfort may lead to misdiagnosis.

Because pulmonary embolism has highly variable manifestations, clinicians must maintain careful diagnostic consideration.

Initial Emergency Management

The initial management of pulmonary embolism focuses on stabilization, oxygenation, circulatory support, and prompt anticoagulation.

Airway and Breathing

Oxygen therapy should be administered to hypoxemic patients. Severe respiratory failure may require mechanical ventilation.

Circulatory Support

Hypotensive patients may require:

Intravenous fluids
Vasopressors
Hemodynamic monitoring

Excessive fluid administration should be avoided because it may worsen right ventricular overload.

Monitoring

Continuous monitoring of:

Heart rate
Blood pressure
Oxygen saturation
Respiratory status

is essential in unstable patients.

Analgesia

Pain control improves respiratory comfort and reduces anxiety.

Immediate Anticoagulation

Anticoagulant therapy should begin promptly when clinical suspicion is high unless contraindications exist.

Anticoagulant Therapy

Anticoagulation is the cornerstone of pulmonary embolism treatment. It prevents clot propagation, reduces recurrence risk, and allows endogenous fibrinolytic mechanisms to dissolve thrombi gradually.

Unfractionated Heparin

Unfractionated heparin acts rapidly and is often used in unstable patients or those requiring procedures because it can be quickly reversed.

It is administered intravenously with monitoring of activated partial thromboplastin time (aPTT).

Low Molecular Weight Heparin (LMWH)

LMWH has more predictable pharmacokinetics and lower risk of heparin-induced thrombocytopenia.

Advantages include:

Subcutaneous administration
Reduced monitoring requirements
Better outpatient suitability

Fondaparinux

Fondaparinux is a synthetic factor Xa inhibitor used as an alternative anticoagulant.

Direct Oral Anticoagulants (DOACs)

DOACs have become increasingly popular due to ease of use and predictable anticoagulant effects.

Examples include:

Rivaroxaban
Apixaban
Edoxaban
Dabigatran

These medications generally do not require routine laboratory monitoring.

Warfarin

Warfarin inhibits vitamin K–dependent clotting factors and requires INR monitoring. Although still widely used, it has largely been replaced by DOACs in many patients.

Duration of Therapy

Treatment duration depends on risk factors and recurrence risk.

Typical durations include:

3 months for provoked PE
Extended therapy for recurrent or unprovoked PE
Long-term therapy in persistent thrombophilia or malignancy

Thrombolytic Therapy

Thrombolytic therapy rapidly dissolves clots and is reserved for severe pulmonary embolism with hemodynamic instability.

Indications

Thrombolysis is indicated in:

Massive PE with shock
Persistent hypotension
Cardiac arrest from PE

Agents Used

Common thrombolytic agents include:

Alteplase
Streptokinase
Urokinase

Risks

Major bleeding, especially intracranial hemorrhage, is the most serious complication. Careful patient selection is therefore essential.

Catheter-Directed Therapy

Catheter-directed therapy has emerged as an important treatment option for selected patients with pulmonary embolism, particularly those who are hemodynamically unstable or have contraindications to systemic thrombolysis.

These minimally invasive procedures are performed using catheter-based techniques inserted through large veins, usually the femoral or jugular vein, and advanced into pulmonary arteries under imaging guidance.

Catheter-Directed Thrombolysis

In this technique, low-dose thrombolytic agents are delivered directly into the clot through specialized catheters. Direct delivery allows lower systemic drug exposure and may reduce bleeding complications compared with systemic thrombolysis.

Advantages include:

Reduced thrombolytic dose
Faster clot dissolution
Improvement in right ventricular function
Lower bleeding risk in selected patients

Mechanical Thrombectomy

Mechanical thrombectomy devices physically fragment, aspirate, or remove thrombi from pulmonary arteries.

Methods include:

Aspiration thrombectomy
Rotational thrombectomy
Rheolytic thrombectomy

Mechanical approaches may rapidly reduce clot burden and improve hemodynamic status.

Indications

Catheter-based therapies are considered in patients with:

Massive pulmonary embolism
Hemodynamic instability
Right ventricular dysfunction
Failure of anticoagulation
Contraindications to systemic thrombolysis

Complications

Potential complications include:

Bleeding
Vascular injury
Arrhythmias
Pulmonary artery perforation
Distal embolization

These procedures should be performed in experienced centers with multidisciplinary expertise.

Surgical Embolectomy

Surgical pulmonary embolectomy is an invasive procedure involving direct surgical removal of emboli from pulmonary arteries.

Indications

It is generally reserved for:

Massive PE with shock
Failure of thrombolytic therapy
Contraindications to thrombolysis
Large intracardiac thrombi
Impending cardiovascular collapse

Procedure

The surgery is performed under cardiopulmonary bypass. Surgeons open the pulmonary arteries and extract obstructing thrombi.

Outcomes

Advances in surgical techniques and perioperative care have improved survival rates, especially when surgery is performed early before irreversible hemodynamic collapse develops.

Risks

Complications include:

Bleeding
Infection
Arrhythmias
Stroke
Postoperative right ventricular failure

Although highly invasive, surgical embolectomy can be lifesaving in carefully selected patients.

Inferior Vena Cava (IVC) Filters

Inferior vena cava filters are devices inserted into the inferior vena cava to prevent emboli from reaching pulmonary circulation.

Mechanism

The filter traps thrombi originating from lower extremity veins while allowing normal venous blood flow.

Indications

IVC filters are mainly indicated in patients who:

Cannot receive anticoagulation
Have active bleeding
Experience recurrent PE despite adequate anticoagulation

Types

Filters may be:

Permanent
Retrievable

Retrievable filters are preferred whenever possible to reduce long-term complications.

Complications

Potential complications include:

Filter thrombosis
Migration
Caval perforation
Recurrent DVT
Device fracture

Because of these risks, IVC filters should not replace anticoagulation when anticoagulant therapy is feasible.

Massive Pulmonary Embolism

Massive pulmonary embolism is the most severe form of PE and is associated with high mortality.

Definition

Massive PE is characterized by:

Sustained hypotension
Cardiogenic shock
Need for vasopressors
Cardiac arrest

These findings result from extensive obstruction of pulmonary circulation and acute right ventricular failure.

Clinical Features

Patients may present with:

Severe dyspnea
Cyanosis
Syncope
Altered consciousness
Chest pain
Extreme tachycardia
Profound hypotension

Pathophysiology

Large emboli obstruct pulmonary arteries, causing abrupt elevation in pulmonary vascular resistance. The right ventricle fails acutely, leading to decreased left ventricular filling and severe systemic hypotension.

Management

Treatment requires aggressive supportive care including:

Oxygenation
Vasopressors
Thrombolysis
Catheter intervention
Surgical embolectomy in selected cases

Rapid diagnosis and intervention are essential because mortality is extremely high without treatment.

Submassive Pulmonary Embolism

Submassive PE occupies an intermediate severity category between massive and low-risk PE.

Characteristics

Patients are hemodynamically stable but exhibit evidence of right ventricular strain or myocardial injury.

Features include:

Elevated cardiac biomarkers
Right ventricular dysfunction on imaging
ECG evidence of strain

Clinical Importance

Although blood pressure remains stable initially, these patients are at risk for sudden deterioration.

Management

Standard anticoagulation is required. Selected patients with worsening clinical status may benefit from thrombolytic or catheter-directed therapy.

Low-Risk Pulmonary Embolism

Low-risk PE refers to hemodynamically stable patients without evidence of right ventricular dysfunction or myocardial injury.

Prognosis

These patients generally have favorable outcomes with appropriate anticoagulation.

Outpatient Management

Some carefully selected low-risk patients may be treated as outpatients using direct oral anticoagulants and close follow-up.

Criteria for outpatient management include:

Stable vital signs
Adequate oxygenation
Low bleeding risk
Reliable follow-up access
Absence of major comorbidities

Pulmonary Embolism During Pregnancy

Pregnancy is a hypercoagulable state associated with increased risk of venous thromboembolism.

Why Risk Increases

Several physiological changes contribute:

Increased clotting factors
Reduced fibrinolysis
Venous stasis from uterine compression
Reduced mobility

The postpartum period carries especially high thrombotic risk.

Clinical Challenges

Diagnosis is difficult because normal pregnancy itself causes:

Dyspnea
Leg swelling
Tachycardia

These symptoms overlap with pulmonary embolism.

Diagnostic Imaging

Imaging strategies attempt to minimize fetal radiation exposure while maintaining diagnostic accuracy.

Treatment

Low Molecular Weight Heparin is the preferred anticoagulant during pregnancy because it does not cross the placenta.

Warfarin is generally avoided during pregnancy due to teratogenicity.

Direct oral anticoagulants are not routinely recommended in pregnancy because safety data remain limited.

Pulmonary Embolism in Cancer Patients

Cancer-associated thrombosis is a major cause of morbidity and mortality.

Mechanisms

Cancer promotes thrombosis through:

Tumor procoagulant substances
Chronic inflammation
Endothelial injury
Chemotherapy effects
Immobility

High-Risk Malignancies

Cancers strongly associated with PE include:

Pancreatic cancer
Lung cancer
Gastric cancer
Brain tumors
Ovarian cancer

Clinical Features

Cancer patients often develop recurrent thrombosis and may have higher clot burden.

Treatment

Anticoagulation remains essential, although bleeding risk is often elevated.

Low Molecular Weight Heparin has historically been preferred, though direct oral anticoagulants are increasingly used in selected patients.

Chronic Thromboembolic Pulmonary Hypertension (CTEPH)

Chronic thromboembolic pulmonary hypertension is a serious long-term complication of pulmonary embolism.

Pathogenesis

Persistent organized thrombi obstruct pulmonary arteries and cause progressive pulmonary hypertension.

Clinical Features

Patients develop:

Progressive exertional dyspnea
Fatigue
Exercise intolerance
Syncope
Right heart failure

Symptoms may develop gradually over months after an acute PE episode.

Diagnosis

Diagnosis involves:

Echocardiography
Ventilation-perfusion scanning
Right heart catheterization
Pulmonary angiography

Treatment

Management options include:

Lifelong anticoagulation
Pulmonary endarterectomy surgery
Balloon pulmonary angioplasty
Pulmonary vasodilator therapy

Pulmonary endarterectomy can be curative in suitable patients.

Complications of Pulmonary Embolism

Pulmonary embolism can produce numerous acute and chronic complications.

Acute Right Ventricular Failure

Severe PE increases right ventricular afterload, leading to acute failure and cardiogenic shock.

Sudden Cardiac Death

Massive embolism may cause sudden circulatory collapse and death.

Pulmonary Infarction

Distal emboli may cause ischemic necrosis of lung tissue with pleuritic pain and hemoptysis.

Arrhythmias

Atrial fibrillation and other arrhythmias may occur due to right heart strain.

Recurrent Pulmonary Embolism

Without adequate anticoagulation, recurrence risk remains substantial.

Chronic Pulmonary Hypertension

Persistent pulmonary vascular obstruction may result in chronic pulmonary hypertension and progressive right-sided heart failure.

Bleeding Complications

Anticoagulant and thrombolytic therapies increase bleeding risk, including gastrointestinal bleeding and intracranial hemorrhage.

Nursing Management

Nursing care plays a crucial role in the management and recovery of patients with pulmonary embolism.

Monitoring

Nurses closely monitor:

Respiratory status
Oxygen saturation
Heart rate
Blood pressure
Neurological status

Early recognition of deterioration is essential.

Oxygen Therapy

Supplemental oxygen is administered as prescribed to improve oxygenation.

Medication Administration

Nurses ensure accurate administration of:

Anticoagulants
Thrombolytics
Analgesics
Vasopressors

Monitoring for adverse effects and bleeding is critical.

Bleeding Precautions

Patients receiving anticoagulation require careful bleeding assessment including:

Gum bleeding
Hematuria
Melena
Bruising
Neurological changes suggesting intracranial hemorrhage

Emotional Support

Anxiety is common in pulmonary embolism. Emotional reassurance and patient education help reduce fear and improve cooperation.

Mobilization

Gradual mobilization is encouraged once clinically stable to reduce venous stasis and improve recovery.

Patient Education

Patients must understand:

Medication adherence
Signs of recurrent PE or DVT
Bleeding precautions
Importance of follow-up care
Lifestyle modifications

Prevention of Pulmonary Embolism

Prevention is extremely important because many pulmonary emboli are preventable.

Early Mobilization

Encouraging movement after surgery or hospitalization reduces venous stasis.

Mechanical Prophylaxis

Methods include:

Graduated compression stockings
Intermittent pneumatic compression devices

These improve venous return from lower limbs.

Pharmacologic Prophylaxis

High-risk hospitalized patients often receive preventive anticoagulation using:

Enoxaparin
Heparin
Fondaparinux

Lifestyle Measures

Preventive strategies include:

Smoking cessation
Weight control
Regular exercise
Adequate hydration
Avoiding prolonged immobilization

Long-Distance Travel Precautions

Travelers should:

Walk periodically
Perform calf exercises
Maintain hydration
Avoid excessive alcohol intake

High-risk travelers may require medical prophylaxis.